These medications are increasingly recognized for their role in lowering the risk of adverse outcomes, making them a valuable option in managing cardiovascular health
log-rank p=0.14), along with a potential increased risk of arrhythmic events.43,44 Given these neutral-to-concerning results, there is currently no evidence to support initiating GLP-1RAs for the primary treatment of HFrEF
As such, these results should be regarded as the starting point for further mechanistic studies aimed at elucidating the signal transduction of vitamin D antioxidant effects in human venous samples
& Cheng G., Crit Rev Immunol, 2012
Beef liver is particularly valuable when it comes to glutathione production
PlexusDx medication protocols are designed to complement, not replace, existing cardiac medications